-
-
-
-
-
-
-
The Newest Name on Nasdaq Wants to Help the Body Rebuild Itself
-
-
-
-
-
-
-
Vericel Reports Fourth Quarter and Full-Year 2025 Financial Results
-
-
-
-
-
-
-
Vericel (VCEL) Tops Q2 EPS by 2c
-
-
-
-
-
-
-
Vericel to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 27, 2025
-
-
-
-
-
-
-
Vericel (VCEL) Misses Q2 EPS by 1c
-
-
-
-
-
-
-
Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance
-
-
-
-
-
-
-
Vericel Announces U.S. Commercial Availability of NexoBrid® (anacaulase-bcdb) for the Treatment of Severe Thermal Burns in Adults
-
1,222,631 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

